Past, Present, and Future Strategies for Enhanced Assessment of Embryo's Genome and Reproductive Competence in Women of Advanced Reproductive Age.

Indeed, a recent survey from the ESHRE PGD consortium showed an increasing trend toward blastocyst biopsy in recent years and that in 2016 it was the main strategy for preimplantation genetic testing of embryos (roughly 60% of all PGT procedures, data from ESHRE PGD consortium at the 2018 Annual Meeting in Barcelona).

also in 63,971 other papers